Suppr超能文献

采用系统综合分析方法鉴定肺结节病和肺结核的生物标志物。

Identification of Biomarkers for Sarcoidosis and Tuberculosis of the Lung Using Systematic and Integrated Analysis.

机构信息

Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, Jilin, China (mainland).

Department of Oncology and Hematology, The Second Hospital of Jilin University, Changchun, Jilin, China (mainland).

出版信息

Med Sci Monit. 2020 Jul 23;26:e925438. doi: 10.12659/MSM.925438.

Abstract

BACKGROUND Sarcoidosis (SARC) is a multisystem inflammatory disease of unknown etiology and pulmonary tuberculosis (PTB) is caused by Mycobacterium tuberculosis. Both of these diseases affect lungs and lymph nodes and share similar clinical manifestations. However, the underlying mechanisms for the similarities and differences in genetic characteristics of SARC and PTB remain unclear. MATERIAL AND METHODS Three datasets (GSE16538, GSE20050, and GSE19314) were retrieved from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) in SARC and PTB were identified using GEO2R online analyzer and Venn diagram software. Functional enrichment analysis was performed using Database for Annotation, Visualization and Integrated Discovery (DAVID) and R packages. Two protein-protein interaction (PPI) networks were constructed using Search Tool for the Retrieval of Interacting Genes database, and module analysis was performed using Cytoscape. Hub genes were identified using area under the receiver operating characteristic curve analysis. RESULTS We identified 228 DEGs, including 56 common SARC-PTB DEGs (enriched in interferon-gamma-mediated signaling, response to gamma radiation, and immune response) and 172 SARC-only DEGs (enriched in immune response, cellular calcium ion homeostasis, and dendritic cell chemotaxis). Potential biomarkers for SARC included CBX5, BCL11B, and GPR18. CONCLUSIONS We identified potential biomarkers that can be used as candidates for diagnosis and/or treatment of patients with SARC.

摘要

背景

结节病(SARC)是一种病因不明的多系统炎症性疾病,而肺结核(PTB)是由结核分枝杆菌引起的。这两种疾病都影响肺部和淋巴结,且具有相似的临床表现。然而,SARC 和 PTB 之间在遗传特征上的相似性和差异性的潜在机制尚不清楚。

材料与方法

从基因表达综合数据库(GEO)中检索了三个数据集(GSE16538、GSE20050 和 GSE19314)。使用在线分析器 GEO2R 和 Venn 图软件鉴定 SARC 和 PTB 中的差异表达基因(DEGs)。使用数据库注释、可视化和综合发现(DAVID)和 R 包进行功能富集分析。使用搜索工具检索相互作用基因数据库构建了两个蛋白质-蛋白质相互作用(PPI)网络,并使用 Cytoscape 进行了模块分析。使用受试者工作特征曲线分析确定了枢纽基因。

结果

我们鉴定出 228 个 DEGs,包括 56 个 SARC-PTB 共有 DEGs(富集于干扰素-γ介导的信号转导、对γ射线的反应和免疫反应)和 172 个 SARC 特有 DEGs(富集于免疫反应、细胞钙离子稳态和树突状细胞趋化性)。SARC 的潜在生物标志物包括 CBX5、BCL11B 和 GPR18。

结论

我们鉴定出了一些潜在的生物标志物,可作为 SARC 患者诊断和/或治疗的候选标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/428f/7397754/456c803376b0/medscimonit-26-e925438-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验